Organ | Pathologic alterations | NS-MPLA supplied (Group II) | SP-challenged (Group III) | NS-MPLA treated post-SP challenge (Group IV) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1d | 2d | 3d | 4d | 1d | 5d | 9d | 13d | 1d | 2d | 5d | 9d | 13d | ||
Liver | Hydrobic degeneration | - | - | - | - | + | + | ++ | - | ++ | + | - | - | - |
Lympho plasmo-cytic infiltration | +++ | +++ | +++ | + | + | + | ++ | + | ++ | ++ | ++ | +++ | ++ | |
Periportal Heterophilic aggregations | - | - | +++ | + | - | - | ++ | - | +++ | ++ | ++ | +++ | ++ | |
Kupffer cell hypertrophy | + | ++ | +++ | + | ++ | + | ++ | - | +++ | ++ | + | +++ | ++ | |
Focal biliray proliferation | - | - | - | - | - | - | - | - | + | + | + | + | - |